United Kingdom Imaging Services Market has valued at USD 13.33 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.05% through 2028.

Pages	85
Market Size
Forecast Market Size
CAGR
Fastest Growing Segment
Largest Market
Key Players

The United Kingdom Diagnostic Imaging Equipment Market Report is Segmented by Modality (MRI, Computed Tomography, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, Mammography), Portability (Fixed Systems, Mobile and Hand-Held Systems), Application (Cardiology, Oncology, Neurology, Orthopedics, and More), and End-User (Hospitals, Diagnostic Imaging Centres, Other End-Users). The Market Forecasts are Provided in Terms of Value (USD).

The U.K. Imaging Services Market size was valued at USD 13.94 billion in 2023 and is projected to reach USD 22.24 billion by 2032, exhibiting a CAGR of 6.9 % during the forecasts period. U. K. imaging services are defined as diagnostic and therapeutic services carried out by various imaging techniques in independent imaging centers, hospitals, diagnostic laboratories or imaging departments in the United Kingdom. They encompass X-rays, Magnetic Resonance Imaging (MRI) scans, Computerized Tomography (CT) scans, ultrasounds, nuclear medicine tests, and mammography used in diagnosing different illnesses and advising on the best treatment methods. They range from common use where clients have regular check ups to imaging that is needed when assessing an ailment, injury or an initial response to a treatment. Some trends are the use of Digital Imaging systems like PACS, telemedicine for remote image interpretation, Role of AI in mangement of image analysis and in the diagnostic process. It is also apparent that there is a growing health care expenditure, the growing need for improved and advanced diagnostic imaging along with in addition to the increasing proportion of the global population that is aging, all located within the U. K.

The size of the United Kingdom Diagnostic Imaging Equipment Market was valued at USD 1.26 Million in 2023 and is projected to reach USD 1.85 Million by 2032, with an expected CAGR of 5.68% during the forecast period. With increasingly accretive demand for proper diagnostic solutions, UK-based diagnostic imaging equipment is widely known to be under an observable growth curve in the wake of technological advancements. An often-recognized chronic condition, such as cancer, cardiovascular disorders, and neurological conditions, places the importance of effective imaging modalities in the healthcare system at a paramount level. The main contributors to sector growth are a strong and holistic level of investment in healthcare infrastructure and development efforts targeted at upgrading existing facilities. NHS and private healthcare service providers are increasingly integrating cutting-edge imaging technologies into practice for enhancing the diagnosis, patient care, and workflow from the diagnostic perspective. Preventive health care and the increased prevalence of early disease detection boost demand for diagnostic imaging services. Most importantly, demographic factors in the UK-the aging population-have established a basic requirement for the company's safe imaging solutions as elderly patients, due to their frail state of health, have to be diagnosed frequently and thoroughly. However, the company will face challenges from its involvement within the NHS's budgetary constraints and the associated cost of equipment used in the imaging business that could possibly shift market dynamics. Regulatory compliance and the requirement for skilled personnel can also be a challenge. Still, research and development are continuous, and governments back innovation within the health care sector. With this support for improved patient outcomes and better quality of care, the UK diagnostic imaging equipment market is poised to grow even further. Recent developments include: May 2022: GE Healthcare and Alliance Medical signed an agreement to collaborate on a digital solution using data analytics and Al to improve productivity in hospital radiology departments in the United Kingdom., May 2022: InHealth Services received Quality Standard for Imaging (QSI) accreditation in the United Kingdom.. Key drivers for this market are: Rise in the Prevalence of Chronic Diseases, Growing Adoption of Advanced Technologies in Medical Imaging. Potential restraints include: Expensive Procedures and Equipment. Notable trends are: MRI Segment is Expected to Hold a Significant Market Share Over the Forecast Period.

In UK Medical Imaging Market, The radiology module of Sectra One, an enterprise imaging solution, is installed and used by GOSH.

Snapshot img

Refurbished Medical Imaging Equipment Market Size 2025-2029

The refurbished medical imaging equipment market size is forecast to increase by USD 7.68 billion, at a CAGR of 8.5% between 2024 and 2029.

The market is driven by the increasing demand for cost-effective and efficient medical imaging devices. As healthcare costs continue to rise, the affordability of refurbished equipment becomes an attractive option for healthcare providers. Furthermore, the adoption of eco-friendly practices in the healthcare industry is fueling the market's growth, as refurbished equipment offers a sustainable solution to reducing the environmental impact of medical waste. However, the market faces challenges, including the negative perception of end-users about refurbished medical equipment. Some healthcare providers may view refurbished equipment as less reliable or less advanced than new equipment. Addressing these concerns through certification programs and ensuring the highest quality standards can help alleviate these concerns and expand the market's reach. Companies seeking to capitalize on market opportunities should focus on providing top-notch customer service, offering flexible financing options, and ensuring the highest quality standards for their refurbished medical imaging equipment. By addressing the challenges and leveraging the market's drivers, companies can effectively navigate the competitive landscape and capture a significant share of the market.

What will be the Size of the Refurbished Medical Imaging Equipment Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free SampleThe market continues to evolve, driven by the ever-changing dynamics of technology and healthcare sector requirements. MRI machines, CT scanners, and X-ray systems are continually upgraded to enhance image quality and enable advanced applications such as precision medicine, image registration, and personalized medicine. Efficiency improvements are a key focus, with equipment financing, quality assurance, and asset management solutions facilitating cost optimization and seamless hospital workflow. CE marking and regulatory compliance ensure the safe and effective use of refurbished imaging equipment. Advancements in medical imaging technology, including 3D imaging, image segmentation, and image analysis, are revolutionizing disease diagnosis and interventional radiology. Big data analytics and artificial intelligence (AI) are increasingly integrated into medical imaging software for early detection and treatment planning. Emerging technologies like image fusion, contrast agents, noise reduction, and machine learning are transforming the industry, offering significant benefits in terms of spatial resolution, contrast resolution, and diagnostic accuracy. Preventive screening and patient monitoring are also gaining importance, with remote diagnostics and real-time image interpretation becoming essential components of the healthcare ecosystem. The ongoing adoption of technology in healthcare is leading to the obsolescence of traditional imaging systems. Maintenance and repair services, along with upgrade options, are crucial for extending the life cycle of refurbished medical imaging equipment. In the realm of cardiovascular imaging, advancements in image acquisition, image processing, and image optimization are enabling more accurate and timely diagnosis. Radiation shielding and image interpretation tools are also essential for ensuring the safety and effectiveness of diagnostic imaging. The integration of medical imaging with healthcare informatics, DICOM standards, and cloud computing is streamlining the management and sharing of medical images, making them more accessible and valuable for clinical trials and research purposes. In conclusion, the market is a dynamic and evolving landscape, characterized by continuous innovation and adaptation to the changing needs of the healthcare sector. From image acquisition and processing to diagnostic accuracy and patient care, refurbished medical imaging equipment plays a crucial role in enhancing the quality and accessibility of healthcare services.

How is this Refurbished Medical Imaging Equipment Industry segmented?

The refurbished medical imaging equipment industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. ProductX-ray imagingUltrasound systemsMRICT scanner imagingSPECT/ PET scannersEnd-userHospitalsDiagnostic centersApplicationCardiovascularOncologyOrthopedicsGynecologyOthersGeographyNorth AmericaUSCanadaEuropeFranceGermanyItalyUKAPACChinaIndiaJapanSouth AmericaBrazilRest of World (ROW).

By Product Insights

The x-ray imaging segment is estim

The United Kingdom diagnostic imaging equipment market, valued at approximately £1.26 billion in 2025, is projected to experience robust growth, exhibiting a Compound Annual Growth Rate (CAGR) of 5.68% from 2025 to 2033. This expansion is fueled by several key factors. Firstly, the aging population in the UK is leading to an increased prevalence of chronic diseases requiring advanced diagnostic imaging techniques. Secondly, technological advancements in medical imaging, such as the development of AI-powered image analysis and improved resolution in modalities like MRI and CT scans, are driving demand for more sophisticated equipment. Furthermore, increased government funding for healthcare infrastructure and initiatives promoting early disease detection are positively impacting market growth. The market is segmented by modality (MRI, CT, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, Mammography), application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology), and end-user (Hospitals, Diagnostic Centers). The competitive landscape is characterized by a mix of established multinational corporations like GE Healthcare, Siemens Healthineers, and Philips, alongside specialized players focusing on niche technologies. While the market faces potential restraints such as high equipment costs and regulatory hurdles, the overall positive trajectory suggests significant growth opportunities in the coming years, particularly for providers offering cutting-edge technologies and integrated solutions. The market's segmentation offers strategic insights. The MRI segment is likely to dominate due to its superior imaging capabilities for various applications, followed closely by CT scanning. The demand for advanced imaging is strong across all applications, with oncology and cardiology segments experiencing substantial growth due to increased cancer diagnoses and cardiovascular disease prevalence. Hospital end-users are expected to remain the largest segment, however, the growth of private diagnostic centers is also contributing significantly to market expansion. Within the competitive landscape, strategic alliances, acquisitions, and technological innovation are key competitive strategies employed by leading players to maintain their market share and expand their offerings. The UK market's strong emphasis on patient care and early disease detection is expected to remain a vital driver for further market development. Recent developments include: May 2022: GE Healthcare and Alliance Medical signed an agreement to collaborate on a digital solution using data analytics and Al to improve productivity in hospital radiology departments in the United Kingdom., May 2022: InHealth Services received Quality Standard for Imaging (QSI) accreditation in the United Kingdom.. Key drivers for this market are: Rise in the Prevalence of Chronic Diseases, Growing Adoption of Advanced Technologies in Medical Imaging. Potential restraints include: Rise in the Prevalence of Chronic Diseases, Growing Adoption of Advanced Technologies in Medical Imaging. Notable trends are: MRI Segment is Expected to Hold a Significant Market Share Over the Forecast Period.

The UK Magnetic Resonance Imaging (MRI) market, a significant segment of the global MRI landscape, is experiencing robust growth driven by several key factors. The increasing prevalence of chronic diseases like cancer, cardiovascular diseases, and neurological disorders fuels demand for advanced diagnostic imaging techniques, with MRI playing a crucial role. Technological advancements, such as the development of higher-field-strength MRI systems offering improved image quality and faster scan times, are also contributing to market expansion. Furthermore, the growing adoption of minimally invasive procedures and the increasing emphasis on early disease detection are creating further opportunities for MRI utilization. Within the UK, government initiatives focusing on improving healthcare infrastructure and access to advanced diagnostic tools are positively impacting market growth. The rising geriatric population, particularly vulnerable to chronic conditions, further strengthens market demand. However, the high cost of MRI systems and procedures, coupled with the need for skilled radiologists and technicians, poses a challenge. Nevertheless, the market is expected to demonstrate sustained growth, primarily driven by the aforementioned factors, particularly within high-field MRI systems offering superior image clarity and enhanced diagnostic capabilities. Competition among established players like GE Healthcare, Siemens Healthcare AG, and Philips is intensifying, leading to innovations in system design and service offerings. The segmentation within the UK MRI market mirrors global trends. High-field MRI systems are expected to dominate due to their superior image quality, while applications such as oncology, neurology, and cardiology are leading the demand. Open MRI systems, offering enhanced patient comfort, are also gaining traction, particularly for patients with claustrophobia. Regional variations within the UK market may exist, reflecting disparities in healthcare infrastructure and spending across different regions. Growth projections for the UK market are positive, aligning with the global CAGR of 5.51%, albeit with potential regional variations. Future growth will hinge on sustained technological advancements, government investment in healthcare, and the successful management of cost-related challenges. Recent developments include: February 2023: Canon Medical Systems launched its Auto Scan Assist, artificial intelligence (AI) software, to streamline the MRI exam workflow. The software will assist United Kingdom National Health Service (NHS) radiology departments in streamlining their planning of MRI exams and enable the automated slice alignment for anatomical studies to reduce the workload burden on radiographers by 80%., August 2022: King's College London led research into breaking the barriers of conventional MRI with the installation of MAGNETOM Free Max from Siemens Healthineers. They also partnered with the Research and Development team to provide additional insight into research projects utilizing other MRI systems, including 1.5T, 3T, and 7T MRI systems from Siemens Healthineers.. Key drivers for this market are: Increasing Prevalence of Chronic Diseases, Increasing Technological Advancements. Potential restraints include: Increasing Prevalence of Chronic Diseases, Increasing Technological Advancements. Notable trends are: Low Field MRI Systems Segment is Expected to Hold a Significant Market Share Over the Forecast Period.

Europe Diagnostic Imaging Market was valued at USD 12.32 Billion in 2024 and is expected to reach USD 16.79 Billion by 2030, growing with a CAGR of 5.25% in the forecast period.

Pages	80
Market Size	2024: USD 12.32 Billion
Forecast Market Size	2030: USD 16.79 Billion
CAGR	2025-2030: 5.25%
Fastest Growing Segment	Ultrasound Systems
Largest Market	Germany
Key Players	1 Siemens Healthineers AG 2 GE Healthcare Europe, GmbH 3 Koninklijke Philips N.V. 4 Agfa-Gevaert N.V. 5 Esaote S.p.A 6 Planmed Oy 7 Carl Zeiss AG 8 Accenture UK Medical Imaging Solutions 9 FUJIFILM Europe GmbH 10 Hologic Europe

The size of the Magnetic Resonance Imaging Market in UK market was valued at USD XXX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 5.51% during the forecast period.Magnetic Resonance Imaging is a medical imaging technique that does not involve invasion. It employs strong magnetic fields and radio waves applied to the body for the creation of images of organs and tissues. MRI scans are highly utilized in the diagnosis of diseases such as brain tumors, spinal cord injuries, musculoskeletal disorders, and cardiovascular diseases.MRI scans show clear images of high resolution and that is why the health care givers can see the inside structures and define abnormalities, which might not come out clear on X-rays and any other imaging techniques. A minute change within the tissue of the brain can help in the diagnosis of many diseases such as multiple sclerosis and Alzheimer's disease by MRI. It is used to inspect the ligament and cartilage damages in the orthopedic fields; to inspect abnormal functions of the heart or vessel abnormalities in the cardiologic fields.The UK MRI market is one of the most prominent markets in the global healthcare sector. Advanced healthcare infrastructure and the increasing aging population and incidence of chronic diseases in the country have been major demand generators for MRI services. Healthcare technology investment by the UK government and the NHS's emphasis on early diagnosis and treatment also boost the market. Recent developments include: February 2023: Canon Medical Systems launched its Auto Scan Assist, artificial intelligence (AI) software, to streamline the MRI exam workflow. The software will assist United Kingdom National Health Service (NHS) radiology departments in streamlining their planning of MRI exams and enable the automated slice alignment for anatomical studies to reduce the workload burden on radiographers by 80%., August 2022: King's College London led research into breaking the barriers of conventional MRI with the installation of MAGNETOM Free Max from Siemens Healthineers. They also partnered with the Research and Development team to provide additional insight into research projects utilizing other MRI systems, including 1.5T, 3T, and 7T MRI systems from Siemens Healthineers.. Key drivers for this market are: Increasing Prevalence of Chronic Diseases, Increasing Technological Advancements. Potential restraints include: Lack Of Proper Reimbursement And Stringent Regulatory Approval Procedures, High Cost of Equipment. Notable trends are: Low Field MRI Systems Segment is Expected to Hold a Significant Market Share Over the Forecast Period.

The industry includes companies that bind printed sheets into books, brochures, magazines and catalogues. Data imaging services involve composition, typesetting, phototypesetting and pre-press data input like scanning and optical character recognition. Companies also advertise plate-making services like imagesetting and plate-setting. Other activities include engraving for gravure, graphic activities and designing printing products.

Snapshot img

Medical Imaging Market Size 2025-2029

The medical imaging market size is forecast to increase by USD 15.2 billion at a CAGR of 6% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing prevalence of chronic conditions leading to an escalating demand for diagnostic imaging. However, the market faces challenges, including the high costs associated with medical imaging equipment and procedures, which may limit accessibility for some patients. MRI machines, CT scanners, X-ray systems, and fluoroscopy systems are some of the most commonly used imaging devices, while image processing software, DICOM standard, and image archiving are essential components of the medical imaging ecosystem.
These factors create a complex landscape for market participants, necessitating strategic planning and operational agility to capitalize on opportunities and navigate challenges effectively. Companies must focus on cost reduction strategies, collaborations, and innovation to remain competitive and meet the evolving needs of healthcare providers and patients. This trend is further fueled by the integration of Artificial Intelligenc (AI) technology into medical imaging, enabling faster and more accurate diagnoses.

What will be the Size of the Medical Imaging Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The market encompasses various technologies, including minimally invasive surgery, molecular imaging, confocal microscopy, and image-guided interventions. These innovations have significant social impact by improving diagnostic accuracy and patient outcomes. Cloud computing and data analytics, driven by big data, facilitate efficient workflow and enhance industry standards. Training programs and continuing medical education ensure professionals stay updated with the latest techniques and ethical considerations. Robotic surgery and precision medicine are key trends, while radiation safety and patient safety remain top priorities. Industry professionals employ image guidance systems to ensure quality assurance and adhere to regulatory requirements.

Economic impact is substantial, with healthcare reform driving increased demand for cost-effective solutions. Professional societies and biomedical engineering collaborate to advance technology and address challenges. Molecular imaging and confocal microscopy contribute to early disease detection and personalized treatment plans. Quality assurance and workflow efficiency are essential for delivering optimal patient experiences. Service contracts and ongoing partnerships ensure seamless integration and maintenance of these advanced systems.

How is this Medical Imaging Industry segmented?

The medical imaging industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

End-user

  Hospitals
  Diagnostic imaging centers
  Others


Product

  X-ray imaging
  Ultrasound imaging
  MRI
  CT scanner imaging
  SPECT/PET imaging


Application

  Cardiology
  Oncology
  Orthopedics and musculoskeletal
  Neurology
  Others


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    Spain
    UK


  APAC

    China
    Japan


  South America

    Brazil


  Rest of World (ROW)

By End-user Insights

The hospitals segment is estimated to witness significant growth during the forecast period. The market is witnessing significant growth, with hospitals leading the adoption of advanced imaging technologies. Hospitals serve as the primary hub for comprehensive patient care and diagnostic procedures, utilizing a range of imaging modalities such as MRI, CT, ultrasound, X-ray, and nuclear imaging systems. These technologies enable early disease detection, support clinical decision-making, and facilitate minimally invasive treatments. The emphasis on precision medicine and personalized care has driven the demand for more sophisticated imaging solutions, offering higher resolution, faster processing, and improved diagnostic accuracy. Image analysis, reconstruction, and segmentation are crucial components of the market, with AI-powered solutions gaining popularity for their ability to enhance diagnostic accuracy and streamline clinical workflows.

Telemedicine applications and remote diagnosis have become increasingly important, especially during the ongoing pandemic, allowing healthcare professionals to assess patients from a distance. Medical device manufacturers continue to innovate, developing new imaging technologies such as 3D image rendering, virtual reality applications, and object detection. Radiation therapy, on

United Kingdom Diagnostic Imaging Equipment Market Outlook 2031:

The United Kingdom diagnostic imaging market size was valued at USD 1.13 Billion in 2022 and is projected to reach USD 1.86 Billion by 2031, expanding at a CAGR of 5.68% during the forecast period 2023 - 2031. The growth of the market is attributed to the increase in the incidence of chronic illnesses, and a growth in the elderly population.



According to national official statistics provided to Eurostat and the OECD, on 5 March 2019, 24.4 percent of the UK population was at risk due to a history of at least one underlying health condition, including 8.3 percent of school-aged children, 19.6 percent of working-age adults, and 66.2 percent of people aged 70 and up. Multimorbidity affected 7.1% of the population.

The number of persons in England with one chronic condition is expected to remain largely steady over the next ten years. Those with numerous chronic health issues, on the other hand, are expected to increase to 2.9 million in 2018 from 1.9 million in 20083.



According to the Scottish Health Survey, 46 percent of individuals aged 16 and over have at least one chronic health condition, and the prevalence rises with age, from 25 percent of adults aged 16-24 to 77 percent of those aged 75 and over4. However, those under the age of 65 are more likely to have multimorbidity in Scotland than people over the age of 655.



The National Health Service (NHS) in the United Kingdom (UK) covers the whole population and is funded by general taxes and managed by the Department of Health. However, responsibility for purchasing health care services in the United Kingdom is devolved at the component nation level, with Primary Care Trusts in England, Health Boards in Scotland, local health groups in Wales, and Primary Care Partnerships in Northern Ireland.



According to our new data, one in every ten adults over the age of 40 in the UK currently has Type 2 diabetes. According to the new numbers, there are 3.8 million people in the UK

The European diagnostic imaging market, valued at approximately $8.47 billion in 2025, is projected to experience robust growth, exhibiting a Compound Annual Growth Rate (CAGR) of 5.9% from 2025 to 2033. This expansion is fueled by several key factors. The increasing prevalence of chronic diseases like cancer, cardiovascular conditions, and neurological disorders necessitates frequent diagnostic imaging procedures. Technological advancements, such as the development of AI-powered image analysis and minimally invasive imaging techniques, are improving diagnostic accuracy and efficiency, driving market growth. Furthermore, rising geriatric populations across Europe, who generally require more frequent diagnostic imaging, contribute significantly to market demand. Government initiatives aimed at improving healthcare infrastructure and increasing access to advanced imaging technologies are also playing a supportive role. Germany, the UK, and Sweden are key markets within Europe, driving regional growth. However, the market also faces challenges, including high equipment costs, stringent regulatory approvals, and the potential for data privacy concerns related to the increasing use of digital imaging. Competition within the European diagnostic imaging market is intense, with established players like GE Healthcare, Siemens Healthineers, Philips, and Fujifilm competing with emerging companies. These companies employ diverse competitive strategies, including product innovation, strategic partnerships, and mergers and acquisitions, to gain market share. Key segments within the market include X-rays, ultrasound, MRI scans, and CT scans, each exhibiting unique growth trajectories influenced by technological progress and specific clinical applications. The market is further segmented by modality, end-user, and geography, providing opportunities for targeted market penetration. Risks include price pressures from healthcare payers, potential disruptions from emerging technologies, and evolving reimbursement policies. A comprehensive understanding of these market dynamics is crucial for stakeholders to navigate the competitive landscape and capitalize on growth opportunities.

The industry includes companies that are involved in the printing of products like newspapers, books, periodicals, business forms and greeting cards. They also have support activities like bookbinding, plate-making services and data imaging. Printing is carried out using various techniques and different materials.

According to Cognitive Market Research, the global Medical imaging information system market size will be USD 43521.6 million in 2025. It will expand at a compound annual growth rate (CAGR) of 5.50% from 2025 to 2033.

North America held the major market share for more than 40% of the global revenue with a market size of USD 16102.99 million in 2025 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2025 to 2033.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 12621.26 million.
APAC held a market share of around 23% of the global revenue with a market size of USD 10445.18 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2025 to 2033.
South America has a market share of more than 5% of the global revenue with a market size of USD 1653.82 million in 2025 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2033.
Middle East had a market share of around 2% of the global revenue and was estimated at a market size of USD 1740.86 million in 2025 and will grow at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2033.
Africa had a market share of around 1% of the global revenue and was estimated at a market size of USD 957.48 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2033.
The computed tomography segment has the fastest CAGR during the forecast period

Market Dynamics of Medical imaging information system Market

Key Drivers for Medical imaging information system Market

Increasing healthcare expenditure drives growth in the medical imaging information system Market

Increasing healthcare expenditure is expected to drive future growth in the medical imaging information system Market. Healthcare expenditure is the total amount of money spent on healthcare goods and services, which includes personal health care, such as curative care, rehabilitative care, long-term care, ancillary services, and medical goods, as well as collective services, such as prevention and public health services, but does not include investment spending. Healthcare spending has a significant impact on medical imaging services by facilitating medical decision-making and patient care. The growing number of diverse and novel imaging technologies has resulted in an increased demand for cost-effectiveness modeling in diagnostic imaging. For instance, in May 2023, according to a report published by the Office for National Statistics, a UK-based government department, healthcare spending in the UK increased by 5.6% between 2022 and 2023, compared to 0.9% growth in 2022. In 2023, UK healthcare expenditure was estimated to be around $317.63 billion (£292 billion). As a result, rising healthcare spending is fueling the expansion of the medical imaging information system Market

https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem/bulletins/ukhealthaccounts/2022and2023

The rising prevalence of chronic illnesses fuels growth in the medical imaging information system Market

The rising prevalence of chronic illnesses is expected to drive the growth of the medical imaging information system Market in the near future. Chronic illness is a medical condition or illness that typically lasts three months or longer and has the potential to worsen over time. Chronic illnesses are more common in older people, and while they can often be managed, they cannot be cured. The growing number of chronic illnesses stimulates the medical imaging market because it is used in the diagnosis and detection of chronic diseases. For instance, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, predicts that by 2050, the number of people aged 50 and up who have at least one chronic illness will increase by 99.5%, from 71.522 million in 2020 to 142.66 million. As a result, the growing prevalence of chronic diseases is driving the medical imaging information system Market

Restraint Factor for the Medical imaging information system Market

Data Security and Privacy Considerations, Will Limit Market Growth

Data protection and privacy concerns are a major impediment to the growth of the medical imaging information systems market. Since such systems handle sensitive patient data and medical images, concerns about unauthorized access, data loss, and regulatory compliance, such as HIPAA,...

The UK Aerial Imaging Market is expected to reach a market value of USD 468.8 million in 2025 and is projected to grow at a CAGR of 8.7%, reaching USD 1,535.8 million by 2035. The market is driven by the increasing demand for geospatial data, advancements in aerial imaging technology, and the growing adoption of unmanned aerial vehicles (UAVs) for various applications.

Attributes	Values
Estimated UK Industry Size in 2025	USD 468.8 million
Projected UK Industry Size in 2035	USD 1,535.8 million
Value-based CAGR from 2025 to 2035	8.7%

Semi-Annual Market Update for UK Aerial Imaging Market

Particular	Value CAGR
H1, 2024	8.3% (2024 to 2034)
H2, 2024	8.5% (2024 to 2034)
H1, 2025	8.6% (2025 to 2035)
H2, 2025	8.9% (2025 to 2035)

An Analysis of UK Aerial Imaging Market by Segment

Component	Market Share (2025)
Hardware	52.80%
Services	47.20%

Application	Market Share (2025)
Defense & Security Intelligence	29.80%
Others	70.20%

Market Concentration and Competitive Landscape

Vendors	Market Share (2025)
DJI	31.5%
Esri	21.7%
Google	18.6%
Microsoft	12.5%
AeroVironment	9.1%
Others	6.6%

The size of the United Kingdom Nuclear Imaging Market was valued at USD 350.43 Million in 2023 and is projected to reach USD 450.69 Million by 2032, with an expected CAGR of 3.66% during the forecast period. The United Kingdom nuclear imaging market is growing at a significant rate, fueled by advanced imaging technologies and the increasing number of chronic diseases. Nuclear imaging includes PET and SPECT, where multiple different techniques are provided for the diagnosis and management of several conditions, including cancer, cardiovascular diseases, and neurological disorders. Nuclear imaging constitutes the most important growth factor, driven by an increasing demand for early and accurate diagnoses. Integrated advanced technologies, such as hybrid imaging systems combining PET with CT, help accomplish diagnostic accuracy. Investments in advanced medical technology from the UK government and improved healthcare services contribute to the growth of the nuclear imaging market. Also, partnerships between health care providers and technological companies create innovative solutions and improved imaging capabilities. However, there are also drawbacks in terms of cost related to nuclear imaging equipment in the market and also requires a specialized training for healthcare professionals. Moreover, factors such as radiation exposure and regulation of radiopharmaceuticals further influence the market forces. Overall, in the near future, nuclear imaging market looked positive for UK. Continued technological advances and focusing on patient outcomes would propel growth in this market over the coming years. As knowledge of benefits of nuclear imaging spread, so too would its impact upon the arena of healthcare. Recent developments include: In September 2021, Advanced Accelerator Applications (AAA) was granted a Promising Innovative Medicine (PIM) designation for 177Lu-PSMA-617, an investigational radioligand therapy by United Kingdom's medicines regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA) for the treatment of certain adults with prostate cancer., In January 2021, Blue Earth Diagnostics, a United Kingdom based company of the Bracco Group has enriched its oncology portfolio by acquiring the license for an exclusive radiopharmaceutical therapeutic technology created by Scintomics GmbH and the Technical University of Munich (TUM).. Key drivers for this market are: Increasing Prevalence of Cancer and Cardiac Disorders, Technological Advancements in Nuclear Imaging. Potential restraints include: Stringent Regulations. Notable trends are: Oncology Holds Significant Share in Application Segment.

Market Size statistics on the Printing, Bookbinding, Plate Services & Data Imaging Services industry in the UK

Snapshot img

Clinical Trial Imaging Market Size 2024-2028

The clinical trial imaging market size is forecast to increase by USD 551.3 million at a CAGR of 7.5% between 2023 and 2028.

The market is experiencing significant growth due to the increasing investment in drug development for chronic diseases. Imaging techniques, such as Computed Tomography (CT), play a crucial role in clinical trials by providing valuable data for drug efficacy and safety assessments. Patient comfort is a key trend in this market, as Breast imaging technologies are being developed to minimize patient discomfort and improve the overall trial experience. Data management services are also gaining importance to ensure accurate and efficient handling of imaging data. Strict regulations, however, pose a challenge to market growth, requiring strong data security and compliance measures. Overall, the market is expected to continue its expansion, driven by the need for advanced imaging technologies to support the development of new treatments.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The integration of medical imaging technologies in clinical trials has revolutionized the biotechnology and pharmaceutical industries. By providing valuable insights into various health conditions, these advanced imaging techniques contribute significantly to the development of new therapeutics and treatments. In the realm of clinical trials, imaging technologies play a pivotal role in assessing the efficacy and safety of new drugs and therapies. Biotechnology and pharmaceutical companies increasingly rely on these technologies to gather data on disease progression, treatment response, and potential side effects. Image analysis software, fueled by artificial intelligence (AI) and machine learning algorithms, is a crucial component of this process. 



These advanced technologies enable the automated detection, measurement, and analysis of various health conditions, including oncology, non-alcoholic steatohepatitis (NASH), neurology, endocrinology, and cardiology. Virtual imaging trials, which utilize AI and machine learning, have gained considerable attention in recent years. These trials allow for remote patient monitoring and data collection, streamlining the clinical trial process and reducing costs. Imaging modalities, such as computed tomography (CT), magnetic resonance imaging (MRI), echocardiography, nuclear medicine (positron emission tomography – PET), x-ray, ultrasound, and optical coherence tomography, are essential tools in the clinical trial landscape.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Modality

  Computed tomography
  Magnetic resonance imaging
  Ultrasound
  Positron emission tomography
  Others


End-user

  Contract research organization
  Pharmaceutical and biotechnology companies
  Research and academic institutes
  Medical device manufacturers


Geography

  North America

    US


  Europe

    Germany
    UK


  Asia

    China
    Japan


  Rest of World (ROW)

By Modality Insights

The computed tomography segment is estimated to witness significant growth during the forecast period.

The market is experiencing notable progressions, with a notable focus on the computed tomography (CT) segment. CT imaging is a vital imaging modality in clinical trials due to its ability to generate detailed cross-sectional images of the body, which are crucial for precise diagnosis and tracking of various medical conditions, including cancer. The rising prevalence of chronic diseases and the demand for early and precise diagnosis have boosted the importance of high-resolution imaging technologies. CT scans are indispensable in evaluating disease progression and treatment effectiveness in clinical trials.

Furthermore, technological innovations in CT imaging, such as photon counting computed tomography (PCCT), are expanding the capabilities of clinical trial imaging. Magnetic Resonance Imaging (MRI), Echocardiography, Nuclear Medicine, Positron Emission Tomography (PET), and X-ray are other significant imaging modalities in clinical trials. MRI offers superior soft tissue contrast and is widely used in neurology, oncology, and cardiology trials. Hence, such factors are fuelling the growth of this segment during the forecast period.

Get a glance at the market report of share of various segments Request Free Sample

The computed tomography segment was valued at USD 317.40 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 38% to the growth of the global market during the